City Therapeutics Closes Upsized $230 Million IPO
The company said the offering included full exercise of the underwriters’ option to purchase additional shares.
Story updates
08:04:15 PM UTC
SquawkNews
City Therapeutics closed its upsized IPO of 12,777,777 shares at $18, including full exercise of the underwriters’ option, for gross proceeds of approximately $230.0M.Material DetailsContext by AI AnalystThis is an early-stage capital raise, expanding cash for RNAi programs before pivotal data. A l…